Original Article
Identification of PRODH as a mitochondria- and angiogenesis-related biomarker for lung adenocarcinoma
Translational Cancer Research
2024;
13
(5)
:2073-2093
.
(31 May 2024)
A novel angiogenesis-associated risk score predicts prognosis and characterizes the tumor microenvironment in colon cancer
Translational Cancer Research
2024;
13
(5)
:2094-2107
.
(31 May 2024)
Systematic proteomics analysis revealed different expression of laminin interaction proteins in breast cancer: lower in luminal subtype and higher in claudin-low subtype
Translational Cancer Research
2024;
13
(5)
:2108-2121
.
(31 May 2024)
Molecular mechanism of RBM14-mediated promotion of proliferation, migration, and invasion in osteosarcoma
Translational Cancer Research
2024;
13
(5)
:2122-2140
.
(31 May 2024)
APOA1 mRNA and serum APOA1 protein as diagnostic and prognostic biomarkers in gastric cancer
Translational Cancer Research
2024;
13
(5)
:2141-2154
.
(31 May 2024)
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria
Translational Cancer Research
2024;
13
(5)
:2155-2163
.
(31 May 2024)
Apigenin suppresses the low oxaliplatin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells via LINC00857
Translational Cancer Research
2024;
13
(5)
:2164-2174
.
(31 May 2024)
Unveiling the role of HACE1 in cervical cancer: implications for human papillomavirus infection and prognosis
Translational Cancer Research
2024;
13
(5)
:2175-2186
.
(31 May 2024)
Comprehensive proteomic profiling of lung adenocarcinoma: development and validation of an innovative prognostic model
Translational Cancer Research
2024;
13
(5)
:2187-2207
.
(31 May 2024)
Tumour mutation burden and infiltrating immune cell subtypes influenced the breast cancer prognosis
Translational Cancer Research
2024;
13
(5)
:2208-2221
.
(31 May 2024)
Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 (ADCY2) in tumorigenesis and prognosis
Translational Cancer Research
2024;
13
(5)
:2222-2237
.
(31 May 2024)
The efficacy of subsequent therapy after failure of anti-PD-1 antibody in metastatic renal cell carcinoma
Translational Cancer Research
2024;
13
(5)
:2238-2250
.
(31 May 2024)
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma
Translational Cancer Research
2024;
13
(5)
:2251-2265
.
(31 May 2024)
Propofol regulates the progression of hepatocellular carcinoma via the POLR2L/TGF-β signaling pathway
Translational Cancer Research
2024;
13
(5)
:2266-2281
.
(31 May 2024)
Expression and prognostic significance of microsomal triglyceride transfer protein in brain tumors: a retrospective cohort study
Translational Cancer Research
2024;
13
(5)
:2282-2294
.
(31 May 2024)
Lanatoside C induces ferroptosis in non-small cell lung cancer in vivo and in vitro by regulating SLC7A11/GPX4 signaling pathway
Translational Cancer Research
2024;
13
(5)
:2295-2307
.
(31 May 2024)
Association between the serum uric acid levels and prostate cancer: evidence from National Health and Nutrition Examination Survey (NHANES) 1999–2010
Translational Cancer Research
2024;
13
(5)
:2308-2314
.
(31 May 2024)
Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience
Translational Cancer Research
2024;
13
(5)
:2315-2331
.
(31 May 2024)
Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy
Translational Cancer Research
2024;
13
(5)
:2332-2345
.
(31 May 2024)
The impact of the location, incidence and distribution of lung metastases in primary colorectal and renal cell cancer patients on prognosis: a retrospective observational study
Translational Cancer Research
2024;
13
(5)
:2346-2356
.
(31 May 2024)
Establishment and validation of a prognostic scoring model based on disulfidptosis-related long non-coding RNAs in stomach adenocarcinoma
Translational Cancer Research
2024;
13
(5)
:2357-2371
.
(31 May 2024)
Molecular, biological characterization and drug sensitivity of chidamide-resistant MCF7 cells
Translational Cancer Research
2024;
13
(5)
:2372-2386
.
(31 May 2024)
CD112 is an epithelial-to-mesenchymal transition-related and immunological biomarker in pan-cancer
Translational Cancer Research
2024;
13
(5)
:2387-2407
.
(31 May 2024)
The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer
Translational Cancer Research
2024;
13
(5)
:2408-2418
.
(31 May 2024)
Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis
Translational Cancer Research
2024;
13
(5)
:2419-2436
.
(31 May 2024)
Up-regulation of NCAPG mediated by E2F1 facilitates the progression of osteosarcoma through the Wnt/β-catenin signaling pathway
Translational Cancer Research
2024;
13
(5)
:2437-2450
.
(31 May 2024)
Efficacy and safety of anlotinib in combination with immune checkpoint inhibitors or not as advanced non-small cell lung cancer treatment: a systematic review and network meta-analysis
Translational Cancer Research
2024;
13
(5)
:2451-2463
.
(31 May 2024)
Comparison of transbronchial biopsy techniques using needle and forceps biopsies in lung cancer for molecular diagnostics: a prospective, randomized crossover trial
Translational Cancer Research
2024;
13
(5)
:2464-2474
.
(31 May 2024)
Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene
Translational Cancer Research
2024;
13
(5)
:2475-2496
.
(31 May 2024)
A novel lactylation-related gene signature for effectively distinguishing and predicting the prognosis of ovarian cancer
Translational Cancer Research
2024;
13
(5)
:2497-2508
.
(31 May 2024)
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study
Translational Cancer Research
2024;
13
(5)
:2509-2517
.
(31 May 2024)
RPN1: a pan-cancer biomarker and disulfidptosis regulator
Translational Cancer Research
2024;
13
(5)
:2518-2534
.
(31 May 2024)
Brief Report
Type I interferon signaling promotes radioresistance in head and neck cancer
Translational Cancer Research
2024;
13
(5)
:2535-2543
.
(31 May 2024)
Review Article
Digital pathology, deep learning, and cancer: a narrative review
Translational Cancer Research
2024;
13
(5)
:2544-2560
.
(31 May 2024)
Case Report
A rare case report of endometrial adenosarcoma in the cesarean scar diverticulum
Translational Cancer Research
2024;
13
(5)
:2561-2563
.
(31 May 2024)
Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma: a case report of a possible abscopal effect
Translational Cancer Research
2024;
13
(5)
:2564-2570
.
(31 May 2024)
Corneal ulcer development due to sintilimab-anlotinib combination therapy-induced dry eye: a case report
Translational Cancer Research
2024;
13
(5)
:2571-2579
.
(31 May 2024)
Editorial Commentary
The role of CD4+ CAR T cells in cancer immunotherapy
Translational Cancer Research
2024;
13
(5)
:2580-2586
.
(31 May 2024)
